Abstract

Down syndrome is the most frequent chromosomal abnormality among live-born infants. All Down syndrome patients have mental retardation and are prone to develop early onset Alzheimer’s disease. However, it has not yet been elucidated whether there is a correlation between the phenotype of Down syndrome and the extra chromosome 21. In this study, we continuously cultivated induced pluripotent stem cells (iPSCs) with chromosome 21 trisomy for more than 70 weeks, and serendipitously obtained revertant cells with normal chromosome 21 diploids from the trisomic cells during long-term cultivation. Repeated experiments revealed that this trisomy rescue was not due to mosaicism of chromosome 21 diploid cells and occurred at an extremely high frequency. We herewith report the spontaneous correction from chromosome 21 trisomy to disomy without genetic manipulation, chemical treatment or exposure to irradiation. The revertant diploid cells will possibly serve a reference for drug screening and a raw material of regenerative medicinal products for cell-based therapy.

Continuously cultivated iPSCs with chromosome 21 trisomy spontaneously reverted to normal diploids. This trisomy rescue occurred without genetic manipulation, chemical treatment, or exposure to irradiation. The revertant cells can serve as a reference for drug screening and as raw materials for regenerative medicine and cell-based therapy.

Details

Title
Autonomous trisomic rescue of Down syndrome cells
Author
Inoue Momoko 1 ; Kajiwara Kazuhiro 1 ; Yamaguchi Ayumi 2 ; Kiyono Tohru 3   VIAFID ORCID Logo  ; Samura Osamu 4 ; Akutsu Hidenori 2 ; Sago Haruhiko 5 ; Okamoto Aikou 4 ; Umezawa Akihiro 2 

 National Center for Child Health and Development, Department of Reproductive Biology, Tokyo, Japan (GRID:grid.63906.3a) (ISNI:0000 0004 0377 2305); The Jikei University School of Medicine, Department of Obstetrics and Gynecology, Tokyo, Japan (GRID:grid.411898.d) (ISNI:0000 0001 0661 2073) 
 National Center for Child Health and Development, Department of Reproductive Biology, Tokyo, Japan (GRID:grid.63906.3a) (ISNI:0000 0004 0377 2305) 
 National Cancer Center Research Institute, Division of Carcinogenesis and Cancer Prevention, Department of Cell Culture Technology, Tokyo, Japan (GRID:grid.272242.3) (ISNI:0000 0001 2168 5385) 
 The Jikei University School of Medicine, Department of Obstetrics and Gynecology, Tokyo, Japan (GRID:grid.411898.d) (ISNI:0000 0001 0661 2073) 
 National Center for Child Health and Development, Department of Maternal-Fetal, Neonatal and Reproductive Medicine, Tokyo, Japan (GRID:grid.63906.3a) (ISNI:0000 0004 0377 2305) 
Pages
885-897
Publication year
2019
Publication date
Jun 2019
Publisher
Nature Publishing Group
ISSN
00236837
e-ISSN
15300307
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2239633257
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.